GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ansell Ltd (OTCPK:ANSLF) » Definitions » EV-to-EBITDA

ANSLF (Ansell) EV-to-EBITDA : 15.09 (As of Dec. 12, 2024)


View and export this data going back to . Start your Free Trial

What is Ansell EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Ansell's enterprise value is $3,054 Mil. Ansell's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $202 Mil. Therefore, Ansell's EV-to-EBITDA for today is 15.09.

The historical rank and industry rank for Ansell's EV-to-EBITDA or its related term are showing as below:

ANSLF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 6   Med: 11.4   Max: 34.49
Current: 15.92

During the past 13 years, the highest EV-to-EBITDA of Ansell was 34.49. The lowest was 6.00. And the median was 11.40.

ANSLF's EV-to-EBITDA is ranked better than
52.19% of 479 companies
in the Medical Devices & Instruments industry
Industry Median: 16.05 vs ANSLF: 15.92

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-12-12), Ansell's stock price is $20.8044. Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.591. Therefore, Ansell's PE Ratio (TTM) for today is 35.20.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).


Ansell EV-to-EBITDA Historical Data

The historical data trend for Ansell's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ansell EV-to-EBITDA Chart

Ansell Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.15 11.27 7.74 9.48 12.46

Ansell Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.74 - 9.48 - 12.46

Competitive Comparison of Ansell's EV-to-EBITDA

For the Medical Instruments & Supplies subindustry, Ansell's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ansell's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ansell's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Ansell's EV-to-EBITDA falls into.



Ansell EV-to-EBITDA Calculation

Ansell's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3053.511/202.3
=15.09

Ansell's current Enterprise Value is $3,054 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's EBITDA for the trailing twelve months (TTM) ended in Jun. 2024 was $202 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ansell  (OTCPK:ANSLF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Ansell's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=20.8044/0.591
=35.20

Ansell's share price for today is $20.8044.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Ansell's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was $0.591.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).

Please read Which price ratio outperforms the enterprise multiple?


Ansell EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Ansell's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Ansell Business Description

Traded in Other Exchanges
Address
678 Victoria Street, Level 3, Richmond, VIC, AUS, 3121
Ansell is a leading supplier of protective gloves for use in healthcare and industrial settings, earning approximately 60% of revenue and 70% of operating profit from the healthcare segment and the remainder from the industrial segment. The company holds a large number of patents and the majority of sales come from its key branded product ranges. Ansell has a global manufacturing and distribution footprint and distributes via key partners as well as directly across more than 100 countries. In fiscal 2022, Ansell earned 45% of revenue in North America, 33% from Europe, Middle East and Africa, 14% across Asia-Pacific and the remaining 8% in Latin America.

Ansell Headlines

From GuruFocus

Half Year 2019 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

PPE Manufacturer Ansell Still Trading at a Nice Valuation

By Holmes Osborne, CFA Holmes Osborne, CFA 05-19-2021

Australian Ansell Expanding Into Medical Supplies

By Holmes Osborne, CFA Holmes Osborne, CFA 02-15-2017

Half Year 2021 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Full Year 2023 Ansell Ltd Trading Update Call Transcript

By GuruFocus Research 02-12-2024

Half Year 2023 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024

Ansell Ltd FY22 Guidance and Trading Update Transcript

By GuruFocus Research 02-12-2024

Half Year 2024 Ansell Ltd Earnings Presentation Transcript

By GuruFocus Research 09-13-2024

Full Year 2019 Ansell Ltd Earnings Call Transcript

By GuruFocus Research 02-12-2024